Entheon Biomedical Corp. is a biotechnology company, which engages in developing and commercializing dimethyltryptamine based psychedelic therapeutic products. Its therapies aim to treat addiction and substance use disorders. The company was founded on June 17, 2019 and is headquartered in Vancouver, Canada.
Industry:
Pharmaceuticals Major